Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief: Merck evaluates consumer business, Perrigo expects more nasal steroid switches, Pfizer consumer sales flat, Sanofi consumer grows nearly 10%

This article was originally published in The Tan Sheet

Executive Summary

Merck evaluates consumer business; Perrigo expects more nasal steroid switches; Pfizer consumer segment flat; Sanofi consumer sales grow nearly 10%; Bayer consumer slips; more Sales & Earnings In Brief

Advertisement

Related Content

“Likely” Merck Consumer-Health Sale Could Bring $8 Billion – Analysts
Nasacort OTC Dual Allergy/Decongestion Relief Could Be Marketing Edge
Pfizer Reorganizes Internally, Closer To Decision On Splitting Business
Herbalife Pushes To Counter Pyramid Scheme Narrative

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel